Magnetic nanoparticles: Suitable for cancer therapy?

May 28, 2008

A measuring procedure developed in the Physikalisch-Technische Bundesanstalt (PTB) can help to investigate in some detail the behaviour of magnetic nanoparticles which are used for cancer therapy.

Magnetic nanoparticles (with a size of some few to several hundred nanometres) are a new, promising means of fighting cancer. The particles serve as a carrier for drugs: "loaded" with the drugs, the nanoparticles are released into the blood stream, where they move until they come under the influence of a targeting magnetic field which holds them on to the tumour – until the drug has released its active agent.

Besides this pharmaceutical effect, also a physical action can be applied: an electromagnetic a.c. field heats up the accumulated particles so much that they destroy the tumour. Both therapeutic concepts have the advantage of largely avoiding undesired side effects on the healthy tissue.

These procedures have already been successfully been applied in the animal model and have, in part, already been tested on patients. Here it is important to know before application whether the particles tend to aggregate and thus might occlude blood vessels.

Information about this can be gained by magnetorelaxometry developed at the PTB. In this procedure, the particles are shortly magnetised by a strong magnetic field in order to measure their relaxation after the switch-off of the field by means of superconducting quantum interferometers, so-called "SQUIDs".

Conclusions on their aggregation behaviour in these media can be drawn from measurements of suspensions of nanoparticles in the serum or in whole blood. As an example, it could be shown in this way that certain nanoparticles in the blood serum form clusters with a diameter of up to 200 nm – a clear indication of aggregation, so that these nanoparticles do not appear to be suitable for therapy.

At present, the high technical effort connected with the use of helium-cooled magnetic field sensors is still standing in the way of using this method routinely in practice. In a joint project with Braunschweig Technical University supported by the Ministry of Education and Research (BMBF), the procedure is currently being transferred to a simpler technology based on fluxgate magnetometers.

Source: Physikalisch-Technische Bundesanstalt

Explore further: Next generation biomarker detects tumour cells and delivers anti-cancer drugs

add to favorites email to friend print save as pdf

Related Stories

Refreshable Braille gets an engineer's touch

Nov 13, 2014

When Katherine (Katie) Cagen '14 was applying to Harvard, she made a new friend on campus who happened to be visually impaired. "I saw how much she relied on technology to be able to access her course materials," ...

What exactly is Google's 'cancer nanodetector'?

Nov 11, 2014

Last week, US tech giants Google made a splash in the media, announcing plans to develop new 'disease-detecting magnetic nanoparticles'. This was almost universally welcomed – after all, trying to detect ...

Recommended for you

A gut reaction

Nov 19, 2014

Queen's University biologist Virginia Walker and Queen's SARC Awarded Postdoctoral Fellow Pranab Das have shown nanosilver, which is often added to water purification units, can upset your gut. The discovery ...

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

E_L_Earnhardt
not rated yet May 29, 2008
If you can COOL the cell you can DE-CELERATE MITOSIS!

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.